美国神经放射科人工智能应用与实施现状:全国调查洞察
美国神经放射学会部门主席工作组于2025年7月14日至8月11日通过电子邮件发放19项横断面问卷,调查美国神经放射科人工智能使用、工具、应用、感知影响、供应商合作与障碍;18名工作组成员中16人(89%)完成,结果以描述性分析呈现。
要点
- 学术型美国神经放射科中人工智能使用已广泛存在(81%),高度集中于卒中相关应用。
- 多数科室主席报告人工智能迄今对工作量影响极小,且工具性能仍不一致。
- 成本、集成困难及缺乏稳健疗效证据是更广泛采用的主要障碍。
核心结论
- 人工智能在美国学术型神经放射科中已广泛使用(81%),但多数科室主席报告其对工作量影响极小且工具性能不一致,实现潜力需临床医生与供应商更紧密合作而非仅增加工具。
研究设计与样本
- 由美国神经放射学会(ASNR)部门主席工作组(18名美国神经放射科医生任科室主席)开发并发放19项横断面问卷,含多选、多选多答及开放式条目,通过电子邮件于2025年7月14日至8月11日发放,18名工作组成员中16人(89%)完成,结果描述性分析。
诊断标准与关键数值
- 学术型美国神经放射科中人工智能使用率为81%,应用高度集中于卒中相关应用,多数科室主席报告其对工作量影响极小且工具性能不一致。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Artificial intelligence (AI) is increasingly integrated into medical imaging, but its adoption across neuroradiology departments remains uneven and poorly characterized. This State of Practice article reports the results of a national survey assessing how US neuroradiology departments are currently using AI - including which tools and applications are most common, how AI is perceived to affect workload and diagnostic performance, the nature of collaboration with AI vendors, and the primary barriers limiting broader adoption.
METHODS: The survey was developed and distributed by the American Society of Neuroradiology (ASNR) Department Chair Working Group, a group of 18 US neuroradiologists serving as department chairs. A 19-item cross-sectional questionnaire - combining multiple-choice, multi-select, and open-ended items covering department demographics, AI usage and tools, clinical applications, perceived impact, vendor collaboration, barriers, pricing models, and future expectations - was distributed by e-mail between July 14 and August 11, 2025. Sixteen of 18 working group members (89%) completed the survey; responses were analyzed descriptively.
KEY MESSAGE: AI use is already widespread among academic US neuroradiology departments (81%), concentrated heavily on stroke-related applications, yet most department chairs report that it has had minimal impact on workload so far and that tool performance remains inconsistent. Cost, integration challenges, and a lack of robust efficacy evidence remain the dominant barriers - underscoring that realizing AI's potential in neuroradiology will require closer collaboration between clinicians and vendors, rather than further tool proliferation alone.
引用
- Wintermark M, Allen JW, Bhala R, et al. Current State of Artificial Intelligence Adoption and Implementation in Neuroradiology Departments: Insights from a US National Survey. AJNR Am J Neuroradiol. 2026. PMID: 41791836. doi:10.3174/ajnr.A9279
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。